Progression of coronary artery calcification after kidney transplantation

Figures & data

Table 1. Patients’ demographic characteristics and most important laboratory parameters.

n = 36	RT group	HD group	p
Patients	20	16	NS
Age	54 ± 9.5 (36–69)	54.4 ± 13.8 (32–74)	NS
HD months	62 ± 26.8 (10–120)	47.5 ± 40 (4–110)	NS
PTH	332 ± 238 (47–1000)	524 ± 587 (75–1900)	NS
Mg	2.6 ± 0.4 (1.9–3.5)	2.5 ± 0.39 (1.6–3.1)	NS
Ca	9.7 ± 1 (7.7–11.2)	9.5 ± 6 (8.7–10.1)	NS
P	5.3 ± 1.2 (4.3–6)	5.9 ± 1.6 (3.7–8.6)	NS
Ca x P	51 ± 16 (33–81)	57 ± 17 (33–84)	NS
Cholesterol	216 ± 44 (175–311)	224 ± 35 (172–280)	NS
CRP	0.68 ± 1 (0.1–3)	0.76 ± 0.7 (0.4–1.6)	NS
Diabetes	2	2	NS
Hypertension	16	13	NS
Smoking	4	3	NS
baseline CS	1343 ± 1692	1186 ± 1440	NS

RT, renal transplantation; HD, hemodialysis; CS, calcium score; NS, not significant.

Figure 1. HD group manifested a significant increase in CS (p = 0.028). Only one patient, who was on a bisphosphonates regimen, manifested a considerable decrease of CS. HD: hemodialysis, CS: calcium score.

Figure 2. RT group did not show any significant change in CS. However, 7 patients manifested a small decrease of CS. RT: renal transplantation, CS: calcium score.

Figure 3. (A) Baseline MSCT and (B) Follow-up MSCT of a HD patient. There is a significant increase of coronary artery calcifications (arrowheads). MSCT: multislice computed tomography, HD: hemodialysis, CS: calcium score.